MALIGNANT MELANOMA: MICROSTAGES AND INDIVIDUALIZED THERAPY
- 1 June 1978
- journal article
- Published by Wiley in Anz Journal of Surgery
- Vol. 48 (3), 282-286
- https://doi.org/10.1111/j.1445-2197.1978.tb05230.x
Abstract
In the prognosis of malignant melanoma the clinical stage and the microstage are the most important factors. According to the microstage, malignant melanomas can be divided into low‐risk and high‐risk melanomas. The subungual‐volar melanoma seems to be an exception. Irrespective of the microstage, the prognosis of this type is probably worse than that of other types of melanoma. In patients with clinical Stage I the therapy should be individualized. In a low‐risk melanoma, a wide local excision iS sufficient; in a high‐risk melanoma an additional regional lymph node dissection appears to be indicated; and if the primary tumour is located on an extremity a hyperthermic perfusion is also called for.Keywords
This publication has 7 references indexed in Scilit:
- Results of Treatment of 269 Patients with Primary Cutaneous MelanomaAnnals of Surgery, 1977
- Biostatistical Basis of Elective Node DissectionAnnals of Surgery, 1977
- Malignes Melanom. Invasionstiefe und MelanomtypBeiträge zur Pathologie, 1976
- Therapie des malignen Melanoms der klinischen Stadien I und IIDeutsche Medizinische Wochenschrift (1946), 1976
- Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage)Cancer, 1975
- The classification of malignant melanoma and its histologic reportingCancer, 1973
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970